PloS one

liver international : official journal of the international association for the study of the liver

internal medicine journal

World journal of virology

[1] An mHealth Framework to Improve Birth Outcomes in Benue State, Nigeria: A Study Protocol

[2] A Patient-Held Smartcard With a Unique Identifier and an mHealth Platform to Improve the Availability of Prenatal Test Results in Rural Nigeria: Demonstration Study

[3] avaliação de cultivares de bananeira (musa sp) na região de selvíria-ms evaluation of banana (musa sp) cultivars in selvíria-ms region

[4] cd8αα expression marks terminally differentiated human cd8+ t cells expanded in chronic viral infection

[5] relationship between hbv dna and hbeag in serum and hbcag and inflammation grade in liver tissue among patients with chronic hepatitis b

[6] anticuerpos anticitomegalovirus y anti-virus de epstein barr pretrasplante renal en cuba

[7] seropositivity of hepatitis b and c among syrian multitransfused patients with hemoglobinopathy

[8] conhecimento dos obstetras sobre a transmissão vertical da hepatite b knowledge of obstetricians about the vertical transmission of hepatitis b virus

[9] risk factors and seroprevalence of hepatitis b, c, and d virus in hemodialysis patients in istanbul

[10] prevalÊncia de doadores com marcadores da hepatite b detectados pela triagem sorolÓgica no instituto onco-hematolÓgico de anÁpolis em 2012 e 2013

[11] research advances in drug resistance to nucleos(t)ide analogues in treatment of chronic hepatitis b

[12] development of hen antihepatitis b antigen igy-based conjugate for elisa assay

[13] effects of nucleos(t)ide analogues on estimated glomerular filtration rate and serum creatinine level in patients with chronic hepatitis b

[14] factors associated with failure of clinical screening among blood donors who have altered serological results in the centro regional de hemoterapia de ribeirão preto

[15] hbv genotype distribution and its relationship with serum hbv dna level and hbeag expression among patients with chronic hepatitis b in southern zhejiang province, china

[16] cyclic thrombocytopenia: a case report

[17] hepatitis b virus genotype e detected in brazil in an african patient who is a frequent traveler

[18] aplicação do modelo de crenças em saúde na prevenção dos acidentes com agulha application of the health belief model to the prevention of occupational needlestick injuries

[19] seropositivity and risk factors of hepatitis b in maharashtra, india

[20] evaluating the immunity against hepatitis b virus among yasuj university of medical sciences students-2014

[21] assessment of different promoters (camv35s, e8, 2a11) in transient expression of hepaptitis b surface antigene (hbsag) in tomato plant

[22] prevalence of antibodies to hepatitis b core antigen in blood donors in the middle west region of brazil

[23] research progress in metabolic activity of natural killer cells in patients with chronic hepatitis b virus infection

[24] frecuencia de hepatitis b y c en adultos con hemopatías malignas frequency of hepatitis b and c in adults with malignant hemopathies

[25] count of peripheral blood dendritic cells and its clinical significance in patients with acute-on-chronic hepatitis b liver failure

[26] an epidemiological serosurvey of hepatitis b virus shows evidence of declining prevalence due to hepatitis b vaccination in central china

[27] seroprevalence of hepatitis b virus infection and associated factors among prison inmates in state of mato grosso do sul, brazil soroprevalência e fatores associados à infecção pelo vírus da hepatite b em população encarcerada no estado do mato grosso do sul, brasil

[28] hepatitis b and skin: review

[29] clinical trial of telbivudine in the treatment of chronic hepatitis b in patients during the third trimester of pregnancy

[30] accidents with biological material and immunization against hepatitis b among students from the health area accidente con material biológico y la vacunación contra la hepatitis b en estudiantes del área de la salud acidente com material biológico e vacinação contra hepatite b entre graduandos da área da saúde

[31] clinical and epidemiological aspects of hepatitis b virus and hepatitis c virus in fortaleza-ceara

[32] seroprevalence of chronic hepatitis b, as determined from dried blood spots, among children and their mothers in central lao people's democratic republic: a multistage, stratified cluster sampling survey

[33] diagnóstico in vivo da asma brônquica

[34] Performance evaluation of NeuMoDx 96 system for hepatitis B and C viral load.

[35] Gold nanoparticles and hepatitis B virus

[36] Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications

[37] Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

[38] Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

[39] Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

[40] Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

[41] Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

[42] Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

[43] Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

[44] Safety and efficacy of entecavir for the treatment of chronic hepatitis B

[45] New approaches in the management of chronic hepatitis B: role of tenofovir

[46] Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

[47] Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

[48] In Silico Screening of Aptamers Configuration against Hepatitis B Surface Antigen

[49] Seroprevalence of Hepatitis B Virus and Associated Factors among Health Professionals in University of Gondar Hospital, Northwest Ethiopia

[50] Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications

[51] Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

[52] Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

[53] Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

[54] Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

[55] Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

[56] Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

[57] Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

[58] Safety and efficacy of entecavir for the treatment of chronic hepatitis B

[59] New approaches in the management of chronic hepatitis B: role of tenofovir

[60] Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

[61] Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

[62] Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.

[63] Clinical factors leading to a change in management in chronic hepatitis B patients managed in a tertiary setting.

[64] What is the optimal timing of antiviral treatment in pregnant hepatitis B carrier with extremely high viral load?

[65] High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation

[66] Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: An open-label, randomized, controlled study

[67] Hepatitis B virus infection: Epidemiology and seroprevalence rate amongst Negrito tribe in Malaysia.

[68] Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.

[69] The impact of schistosomiasis co-infection in the presentation of viral hepatitis B in migrants: An observational study in non-endemic area.

[70] Prevalence of chronic liver disease among young/middle-aged adults in Northern Italy: role of hepatitis B and hepatitis C virus infection by age, sex, ethnicity.

[71] Electronic health informatics data to describe clearance dynamics of hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in chronic hepatitis B virus infection

[72] Hepatitis B and C prevalence and risk factors among young men presenting to the Brazilian Army: A STROBE-compliant national survey-based cross-sectional observational study.

[73] Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town Health institutions, Northwest Ethiopia

[74] Title: p38 mitogen-activated protein kinase impairment of innate immune cells is a characteristic feature of HBeAg-negative chronic hepatitis B.

[75] Association of rs10204525 genotype GG and rs2227982 CC combination in programmed cell death 1 with hepatitis B virus infection risk.

[76] Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.

[77] Targeting Hepatitis B Virus cccDNA and HBx: Recent Advances and New Approaches.

[78] Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.

[79] Assessing the knowledge of expectant mothers on mother–to-child transmission of viral hepatitis B in Upper West region of Ghana

[80] LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling

[81] Effect of a media intervention on hepatitis B screening among Vietnamese Americans.

[82] Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure.

[83] Correlation of CpG methylation of Pdcd1 gene with PD-1 expression on CD8 T cells and medical laboratory indicators in chronic hepatitis B infection.

[84] Metabolomics analysis of the saliva in patients with chronic hepatitis B using nuclear magnetic resonance: a pilot study.

[85] Maternal reasons for non-receipt of valid Hepatitis B birth dose among mother-infant pairs attending routine immunization clinics, South-east, Nigeria.

[86] Surveillance and impact of occult hepatitis B virus, SEN virus, and Torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection.

[87] Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review

[88] Evaluation of the /S Gene Overlapping Mutations in Chronic Hepatitis B Patients in Northern Cyprus.

[89] Dose-dependent pharmacokinetics and tentative identification of urine metabolites from an isosteviol derivative with anti-hepatitis B activity in rats

[90] Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon

[91] Hepatitis B vaccine knowledge and uptake among medical students in Cameroon

[92] Comparing the Effects of Different Story Types and Speakers in Hepatitis B Storytelling Videos.

[93] Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen species.

[94] An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect.

[95] Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.

[96] The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients

[97] Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

[98] Preliminary report of the use on adults of a recombinant yeast-derived hepatitis B vaccine manufactured by Instituto Butantan

[99] Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.

[100] Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection

[101] One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor